Ssangyong Pharmaceutical

　　Wuhan Shuanglong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Hubei Hongyuan Pharmaceutical Technology Co., Ltd., was founded in 1989. It is a high and new technology enterprise integrating drug development, production and sales. Its production base is located at No.9 Yousha Road, Taiwanese Investment Zone, Dongxihu District.

　　The Company pays attention to R&D investment, and introduces more than 200 professional devices and imported inspection instruments. Now it has the four major dosage forms, namely tablets, granules, capsules and oral preparations, and more than 60 NMPN products, involving multiple hot fields. Among these, “Shenyan Siwei Capsule”, “Pudilan Anti-inflammatory Tablet”, “Compound Xingxiang Tuerfeng Capsule”, “Jinlong Shudan Capsule” and other products have been praised as the good medicine for the majority of patients both at home and abroad for their good quality and obvious curative effect. Adhering to the corporate philosophy of "creating benefits for society, creating values for customers and providing opportunities for employees", the Company insists on the operating principle of "making good medicines wholeheartedly, benefiting the country and the people and seeking development", and makes steady steps forward continuously.